Optimizing the Cell Painting assay for image-based profilingBeth A. Cimini, Anne E. Carpenter, John Concannon et al.|Nature Protocols|2023Cited by 156
JUMP Cell Painting dataset: morphological impact of 136,000 chemical and genetic perturbationsSrinivas Niranj Chandrasekaran, Kevin D. Little, Jeanelle Ackerman et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 101
Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialPepijn Eijsvogel, Jean‐Cosme Dodart, Pinaki Misra et al.|Nature Medicine|2024Cited by 38
VXX-401, a novel anti-PCSK9 vaccine, reduces LDL-C in cynomolgus monkeysMadeline M. Vroom, Jean‐Cosme Dodart, Hanxin Lu et al.|Journal of Lipid Research|2024Cited by 23
Preclinical characterization of an active immunotherapy targeting calcitonin gene-related peptideJustin D. Boyd, Jean‐Cosme Dodart, Shixia Wang et al.|Communications Medicine|2025Cited by 2